IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
20. Please explain whether or not your legislation extends to the protection of designs dictated essentially by technical or functional considerations. Please explain how textile designs are protected.
|
The law does not protect anything in an industrial design which serves only to obtain a technical result.
The textile designs are protected like any other design if it is new and it is not scandalous or contrary to morality or public order or is not likely to offend religious or racial susceptibility of any community.
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
21. Please explain how your legislation protects right holders of a design against importing of articles bearing embodied or copied design.
|
Section 44 of the Code grants the exclusive rights to the registered owner including to import, offer or sale, sell or use a product embodying such industrial design.
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
22. Please state whether or not your legislation provides for the right to issue a compulsory licence for industrial designs.
|
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
23. Please indicate for what period of time your legislation grants protection for industrial designs.
|
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
Additional question 13:
Please explain if the provisions of Section 44(1) of Act 52 of 1979 include the right of the owner of a registered design to prevent a third party from committing an act of infringement in relation to "substantially a copy" of the protected design as provided for in Article 26.1 of the TRIPS Agreement.
|
Section 44(3) makes the necessary provisions.
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
24. Please describe how your legislation defines the notions of novelty, inventiveness and industrial application.
|
(i) An invention is new if it is not anticipated by prior art.
(ii) Prior art shall consist of -
everything disclosed to the public, anywhere in the world, by written publication or, in Sri Lanka, by oral disclosure, by use or in any other way, prior to the filing or, where appropriate, priority date of the patent application claiming the invention;
the contents of a domestic patent application having an earlier filing or, where appropriate, priority date than the patent application referred to in paragraph (a), to the extent that such contents are included in the patent granted on the basis of the said domestic patent application.
(iii) A disclosure made under subsection (2)(a) shall be disregarded-
if such disclosure occurred within one year preceding the date of the patent application and if such disclosure was by reason or in consequence of acts committed by the applicant or his predecessor in title;
if such disclosure occurred within six months preceding the date of the patent application and if such disclosure was by reason or in consequence of any abuse of the rights of the applicant or his predecessor in title.
Inventiveness
An invention shall be considered as involving an inventive step if, having regard to the prior art relevant to the patent application claiming the invention, such inventive step would not have been obvious to a person having ordinary skill in the art.
Industrial application
An invention shall be considered industrially applicable if it can be made or used in any kind of industry.
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
25. Please explain whether or not in your legislation, patent or otherwise, patent rights are enjoyed without any exclusions. If exclusions are provided for, please describe in detail how these exclusions are applied in legal as well as practical terms.
|
The patent rights:
• extend only to acts done for industrial or commercial purposes and in particular not to acts done only for scientific research;
• not preclude a person having the rights referred to in Section 83 or a licensee from exploiting the patented invention;
• not extend to the presence or use of products on foreign vessels, aircraft, spacecraft, or land vehicles which temporarily or accidentally enter the waters, airspace or territory of Sri Lanka.
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
26. Please explain whether your legislation provides for the exclusion of inventions from patentability based on ordre public or morality. If so, please explain the relevant section of your legislation and explain its formulation. Please also explain if it has been applied in practice.
|
Under the proposed law any invention, the prevention within Sri Lanka of the commercial exploitation of which is necessary to protect the public order, or morality including the protection of human, animal or plant life or health or the avoidance of serious prejudice to the environment is not patentable.
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
27. Please explain whether or not diagnostic, therapeutic and surgical methods are excluded from patentability in your legislation. If so, please explain the relevant section of your legislation and explain its formulation.
|
Section 59(3)(d) provides that method for the treatment of the human or animal body by surgery or therapy, and diagnostic method practised on human or animal body are not patentable.
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
28. Please explain whether or not plants, animals and essentially biological processes are excluded from patentability in your legislation. If so, please explain the relevant section of your legislation and explain its formulation.
|
Section 59(3)(b) provides that plants or animal varieties or essentially biological processes for the production of plant or animals, other than micro biological processes and the product of such processes are not patentable.
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
29. Please describe how micro-organisms, non-essentially biological processes, microbiological processes and plant varieties are protected in your legislation. Please explain, in this respect, the relevant sections of your legislation.
|
Please see the answer to question no. 28.
A law is being prepared to protect plant varieties under a sui generis system.
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
30. Please explain how your legislation protects patent right holders against the importing and against the offering for sale of a patented invention.
|
Section 81 provides as follows:
When the patent has been granted in respect of a product-
• making, importing, offering for sale, selling and using the product;
• stocking such product for the purpose of offering for sale, selling or using.
When the patent has been granted in respect of a process-
• using the process;
• doing any of the acts referred to in paragraph (a), in respect of a product obtained directly by means of the process.
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
31. Please state if your legislation provides for patent product protection of pharmaceutical and agricultural chemical products. In the affirmative, please indicate the legal reference.
|
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
32. Please clarify if the patent protection of a process, as provided for in your legislation, covers the product obtained directly by that process.
|
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
33. Please explain the additional conditions, if any, in your legislation other than the sufficient disclosure of the invention in Article 29 of the TRIPS Agreement (e.g. submission of justification for access to genetic material or prior inform consent to its use). If such additional conditions exist, please point out the relevant legislation and describe the additional conditions in detail.
|
No additional conditions.
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
34. Please describe if your legislation provides for limited exceptions to the exclusive rights conferred by a parent. If affirmative, please make a reference to relevant legislation.
|
The patent rights:
• extend only to acts done for industrial or commercial purposes and in particular not to acts done only for scientific research;
• not preclude a person having the rights referred to in Section 83 or a licensee from exploiting the patented invention ;
• not extend to the presence or use of products on foreign vessels, aircraft, spacecraft, or land vehicles which temporarily or accidentally enter the waters, airspace or territory of Sri Lanka.
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
35. Please explain whether or not your legislation provides for compulsory licensing. If so, please explain in detail the conditions under which a compulsory licence may be granted. In particular, please explain how your national legislation considers individual merits in the authorization of such use.
|
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
36. Please explain how your legislation explicitly ensures that a proposed user has made efforts to obtain authorization from the right holder on reasonable commercial terms and conditions and that such efforts have not been successful within a reasonable period of time. In this context, how do you define "reasonable period of time". Please also explain how your legislation ensures that the use of a compulsory licence shall be authorized predominantly for the supply to the domestic market of the Member authorizing such use.
|
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
37. Please state if your legislation grants additional protection for innovations after the 20 years of patent protection has lapsed.
|
|
13/10/2003 |
|
IP/Q/LKA/1, IP/Q2/LKA/1, IP/Q3/LKA/1, IP/Q4/LKA/1 |
Sri Lanka |
Unión Europea |
38. Please explain how your legislation provides for the reversal of the burden of proof in relation to process patents.
|
The proposed amendment (Section 81 (A)) provides as follows:
"Where the subject matter of a patent is a process for obtaining a product, the burden of proof in a civil action of establishing that an alleged infringing product was not obtained by that patented process shall be on the alleged infringer-
- if the product obtained by the patented process is new; or
- if a substantial likelihood exists that the product was made by the patented process and the patent owner has been unable through reasonable efforts to determine the process actually used.
In the gathering and evaluation of evidence the legitimate interests of the alleged infringer in protecting his undisclosed information shall be taken into account".
|
13/10/2003 |
|